Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

Ophthalmic Pharmaceuticals, Market Analysis, Forecasts and Dynamics - 2009-2023

BioNewsCast Press Release Distribution Service

Statins: The World Market, 2009-2024

Liver Cancer Drug Pipeline Update 2008

Bioinformatics Markets

New Products

Live Cell & Kinetic HCS Imaging Trends 2008

2008 Trends to Watch: Healthcare Technology

2009 Trends to Watch: Healthcare Technology

Biosimilars Series: Stakeholder Analysis

Biotech M&A Strategies: Deal assessments, trends and future prospects

Building a Network of Networks to Achieve Interoperability in Healthcare (Strategic Focus)

Business Trends - Healthcare Technology (Customer Focus)

Claims Processing for Healthcare Payers (Market Model)

Clinical Decision Support in Healthcare - One step closer to the Omniscient Clinician (Strategic Focus)

Commercial and Pipeline Insight: ADHD - Immature adult market continues to offer greatest commercial potential

BioPortfolio | Select Bioscience Reports

Stem Cells in Regenerative Medicine 2008 Market Report
This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences. This report focuses on the worldwide Regenerative Medicine/Cellular Therapy Marketplace which is a major segment of the overall stem cells space.

Cancer Personalized Medicine 2008
This is the latest most up-to-date Cancer Personalized Medicine Market Report from Select Biosciences. This report presents an up-to-date and thorough analysis of the Cancer Personalized Medicine Marketplace based upon Select Biosciences continuing industry coverage. Personalized Medicine, especially as it relates to Cancer, is undergoing significant growth and this report focuses in on the science, market/commercialization, and diagnostic/therapeutics trends in this space.

Multiplexed Diagnostics 2008 Market Report
Multiplexed diagnostics are the wild west of medicine. Technology is established, regulation is limited and the number of new biomarkers exploding. First-movers are grabbing biomarker territories, combining independent measurements for efficiency and mining molecules for multivariate panels. All the while demand is high for improving diagnoses and predicting responses to treatment. The challenges, however, are uncertain reimbursement, unclear business models and ever-intensifying competition.

Epigenetics and MicroRNA Diagnostics Therapeutics 2008
This is the latest Epigenetics and MicroRNA Diagnostics/Therapeutics Market Report from Select Biosciences. This report presents an up-to-date and thorough analysis of the Epigenetics Marketplace based upon our continuing industry coverage. Epigenetics is undergoing a massive industry expansion and this report focuses in on the science, market, and therapeutics trends in this emerging area.

G-Protein Coupled Receptors (GPCRs) 2007 Market Report
This industry report focuses upon the technology and market trends in the GPCRs target space. Given the central and essential role GPCRs occupy as a drug target class, it is important for industry participants to map the landscape in terms of both biological/technical aspects of the target class as well as the market/business metrics.

Personalized Medicine Market Report 2007
This report presents the latest industry analysis of the emerging field of Personalized Medicine. There is increasing interest in this field driven by the development of a number of molecular diagnostics-based tests that determine a patient’s genetic predisposition to a given disease—such as cancer, or to adverse drug reactions (ADRs).

High-Content Analysis 2007 Market Report
This report presents an industry analysis of the High-Content Analysis Marketplace in both qualitative and quantitative terms. High-Content Analysis involves the use of instrumentation, reagents, and informatics to perform multi-parametric analysis of biological systems ie., lots of different cellular parameters studied in parallel. High-Content Analysis is crucial in the biological characterization [fine-structure characterization] of lead compounds primarily in the drug discovery process. Select Biosciences’ industry tracking of this space involves analyses of the technology trends as well as market analysis of instrumentation and reagents that are utilized in High-Content Analysis. Select Biosciences presents primary market survey data in this report that describe important qualitative and quantitative metrics in the High-Content Analysis marketplace—these parameters describe the marketplace in detail.

RNAi/MicroRNA 2007 Market Report
This report presents an industry analysis of the RNAi and microRNA markets in both qualitative and quantitative terms. Select Biosciences’ industry tracking of these spaces involves analyses of the technology trends as well as market analysis. Select Biosciences presents primary market survey data in this report that describes the qualitative and quantitative metrics in the RNAi and microRNA markets.

In Silico ADME/Tox Products Market 2006
In Silico predictive ADME/Tox screening is one of the hottest areas in drug discovery. It is widely perceived that the early screening of chemical entities can significantly reduce the expensive costs associated with late stage failures of drugs due to poor ADME/Tox properties. This market research report from Select Biosciences provides an up-to-date overview and analysis of technology, business, regulatory trends and key product profiles.

Stem Cells 2007-2008 Market Report
This is the latest Stem Cells Market Report from Select Biosciences. This report presents an up-to-date thorough analysis of the stem cells landscape including quantitative market analysis, industry metrics, intellectual property landscape as well as all the major industry events over the past 18 months. The report contains primary market survey data collected by Select Biosciences from the stem cell community-provides a complete picture of technology and market trends.

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions